Magnoflorine promotes the anticancer effects of doxorubicin by inducing cellular apoptosis and autophagy in breast cancer cells by regulating the p62, mTOR, and p38 signaling pathways.31 The gene discussed is MTOR; the disease is breast carcinoma.